Dublin, Dec. 05, 2024 (GLOBE NEWSWIRE) -- The "Managing Microbiological Out of Specification (OOS) and Out of Trend (OOT) Results in Sterile and Non-Sterile Production FDA & ICH Expectations and ...
Dublin, April 15, 2026 (GLOBE NEWSWIRE)-- The "Webinar: Investigating Out-of-Specification (OOS) Test Results in the Laboratory; FDA Guidance and Latest Expectations (May 5, 2026)" webinar has been ...
This course is designed to be an exploration of best practice for OOS investigations in a GMP environment. The course is aimed at the investigation of all out of expectation (OOE) results, including ...
DUBLIN--(BUSINESS WIRE)--The "OOS and OOT Investigations Course - Best Practices, Key Components and a Comprehensive Review of the FDA Requirements" training has been added to ResearchAndMarkets.com's ...
Late last year, Novartis explained how in certain circumstances, it was providing out-of-specification (OOS) doses of its cell therapy Kymriah (tisagenlecleucel) under a compassionate use program in ...
DUBLIN--(BUSINESS WIRE)--The "3-Hour Virtual Seminar on Handling OOS Test Results and Completing Robust Investigations" webinar has been added to ResearchAndMarkets.com's offering. The seminar aims to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results